Doxycycline compared with azithromycin for treating women with genital Chlamydia trachomatis infections: an incremental cost-effectiveness analysis

Clicks: 533
ID: 118672
1996
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #4 of 62 articles by views in annals of internal medicine

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
On the basis of the best available data as derived from the literature and experts, the azithromycin strategy was more cost-effective than the doxycycline strategy for women with uncomplicated cervical chlamydial infections. Despite the dominance of the azithromycin strategy over the doxycycline str …
Reference Key
d1996annalsdoxycycline Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Magid D;Douglas JM;Schwartz JS;;
Journal annals of internal medicine
Year 1996
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/8554247
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine treatment outcome research support non-u.s. gov't female Drug Administration Schedule Comparative Study sensitivity and specificity multivariate analysis decision trees analysis of variance cost-benefit analysis health care costs chlamydia infections / drug therapy* chlamydia trachomatis* doxycycline / administration & dosage azithromycin / administration & dosage genital diseases female / drug therapy* chlamydia infections / economics pmid:8554247 doi:10.7326/0003-4819-124-4-199602150-00002 d magid j m douglas j s schwartz azithromycin / economics* doxycycline / economics* female / economics

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.